Thyroid remnant ablation: questionable pursuit of an ill-defined goal

Journal Article · Mon Aug 01 04:00:00 EDT 1983 · J. Nucl. Med.; (United States)

OSTI ID:5475343

Snyder, J; Gorman, C; Scanlon, P

Ablative therapy with I-/sup 131/ in 30-mCi doses, directed to postsurgical remnants in patients with differentiated thyroid cancer, reduced visible I-/sup 131/ uptake to zero or nearly zero in 81% of patients but did not protect against tumor recurrence in six of 69 patients who were followed for 2-5 yr. Recurrences developed within 5-37 mo. Effectiveness of 30-mCi doses of I-/sup 131/ in producing ablation did not correlate with I-/sup 131/ uptake by the thyroid remnant, surgeon's estimate of remnant size, or delivered dose to the remnant in rads, calculated using reasonable assumptions. These findings emphasize the difficulty of dosimetric measurements and calculations. The value of postsurgical ablative therapy in diminishing morbidity and mortality in patients with differentiated thyroid cancer has not yet been firmly established, and until this is done we advocate a conservative, economical approach to thyroid ablation with 30-mCi treatment doses of I-/sup 131/ and 1-mCi neck-scanning doses to check on effectiveness of therapy.

• Research Organization: Mayo Clinic, Rochester, Minnesota
• OSTI ID: 5475343
• Journal Information: J. Nucl. Med.; (United States), Journal Name: J. Nucl. Med.; (United States) Vol. 24:8; ISSN JNMEA
• Country of Publication: United States
• Language: English

Related Subjects

550604 -- Medicine-- Unsealed Radionuclides in Therapy-- (1980-)
560161* -- Radionuclide Effects
Kinetics
& Toxicology-- Man
62 RADIOLOGY AND NUCLEAR MEDICINE
63 RADIATION, THERMAL, AND OTHER ENVIRON. POLLUTANT EFFECTS ON LIVING ORGS. AND BIOL. MAT.
ADOLESCENTS
AGE GROUPS
BETA DECAY RADIOISOTOPES
BETA-MINUS DECAY RADIOISOTOPES
BODY
CARCINOMAS
DAYS LIVING RADIOISOTOPES
DISEASES
DOSIMETRY
ELDERLY PEOPLE
ENDOCRINE GLANDS
EVALUATION
FEMALES
GLANDS
HUMAN POPULATIONS
INTERMEDIATE MASS NUCLEI
IODINE 131
IODINE ISOTOPES
ISOTOPES
MALES
MEDICINE
MINORITY GROUPS
NEOPLASMS
NUCLEAR MEDICINE
NUCLEI
ODD-EVEN NUCLEI
ORGANS
PATIENTS
POPULATIONS
RADIOISOTOPES
RADIOLOGY
RADIOTHERAPY
THERAPY
THYROID